Skip to main content Accessibility help
×
Home
  • Cited by 2
  • Print publication year: 2006
  • Online publication date: November 2009

18 - Focal brain ischemia models in rodents

Summary

Introduction

Stroke is the second leading cause of mortality worldwide and the third leading cause of death in the United States. Approximately 80% of strokes are ischemic in origin. Stroke ranked as the sixth leading cause of disability-adjusted life years in 1990 and is estimated to rank fourth by the year 2020. Of the stroke survivors about one-half are left with a permanent handicap. It is estimated that 731 000 new strokes per year, 4 000 000 stroke survivors, and 160 000 stroke deaths cost approximately $50 billion (direct and indirect costs) in the USA alone. Given this epidemiological evidence and the magnitude of the problem, it is clear that stroke is a major public health issue and requires urgent effort for developing novel remedies. Experimental focal brain ischemia models serve this purpose.

Experimental focal cerebral ischemia models have been developed with significant effort to mimic closely the changes that occur during and after human stroke. Models help us learn about the pathogenesis of stroke and to define the biochemical changes in tissue during ischemia, thereby discovering mechanisms involved in the evolution of ischemic injury and infarction. This can lead to the development of novel molecules that may reduce the consequences of ischemia and these same animal models can be utilized to test whether these novel molecules have beneficial anti-ischemic effects in vivo.

Related content

Powered by UNSILO
References
Bonita R. Stroke prevention: global perspective. In Norris, JW, Hachinski, V (eds.) Stroke Prevention. New York: Oxford University Press, 2001, pp. 259–274.
Saxena, R, Lewis, S, Berge, E, Sandercock, PA, Koudstaal, PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 2001, 32: 2333–2337.
Sacco, RL, Wolf, PA, Gorelick, PB. Risk factors and their management for stroke prevention: outlook for 1999 and beyond. Neurology 1999, 53: S15–S24.
Kaste, M, Fogelholm, R, Rissanen, A. Economic burden of stroke and the evaluation of new therapies. Public Health 1998, 112: 103–112.
Sacco RL, Boden-Albala B. Stroke risk factors: identification and modification. In Fisher, M (ed.) Stroke Therapy, 2nd edn. Woburn, MA: Butterworth-Heinemann, 2001, pp. 1–24.
del Zoppo, GJ, Poeck, K, Pessin, MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann. Neurol. 1992, 32: 78–86.
Hsu, CY. Criteria for valid preclinical trials using animal stroke models. Stroke 1993, 24: 633–636.
Yamori, Y, Horie, R, Handa, H, Sato, M, Fukase, M. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 1976, 7: 46–53.
Coyle, P. Middle cerebral artery occlusion in the young rat. Stroke 1982, 13: 855–859.
Ginsberg, MD, Busto, R. Rodent models of cerebral ischemia. Stroke 1989, 20: 1627–1642.
STAIR (Stroke Therapy Academic Industry Roundtable) Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999, 30: 2752–2758.
Koizumi, J, Yoshida, Y, Nakazawa, T, Ooneda, G. Experimental studies of ischemic brain edema. I. A new experimental model of cerebral embolism in which recirculation can be introduced in the ischemic area. Jap. J. Stroke 1986, 8: 1–8.
Takano, K, Tatlisumak, T, Bergmann, AG, Gibson, DGI, Fisher, M. Reproducibility and reliability of middle cerebral artery occlusion using a silicon-coated suture (Koizumi) in rats. J. Neurol. Sci. 1997, 153: 8–11.
Belayev, L, Alonso, OF, Busto, R, Zhao, W, Ginsberg, MD. Middle cerebral artery occlusion in the rat by intraluminal suture: neurological and pathological evaluation of an improved model. Stroke 1996, 27: 1616–1623.
Longa, EZ, Weinstein, PR, Carlson, S, Cummins, R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20: 84–91.
Laing, RJ, Jakubowski, J, Laing, RW. Middle cerebral artery occlusion without craniectomy in rats: which method works best? Stroke 1993, 24: 294–298.
Nagasawa, H, Kogure, K. Correlation between cerebral blood flow and histological changes in a new rat model of middle cerebral artery occlusion. Stroke 1989, 20: 1037–1043.
Zarow, GJ, Karibe, H, States, BA, Graham, SH, Weinstein, PR. Endovascular suture occlusion of the middle cerebral artery in rats: effect of suture insertion distance on cerebral blood flow, infarct distribution and infarct volume. Neurol. Res. 1997, 19: 409–416.
Li, F, Han, S, Tatlisumak, T, et al. A new method to improve in-bore middle cerebral artery occlusion in rats: demonstration with diffusion- and perfusion-weighted imaging. Stroke 1998, 29: 1715–1720.
Meng, X, Fisher, M, Shen, Q, Sotak, CH, Duong, TQ. Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann. Neurol. 2004, 55: 207–212.
Kuge, Y, Minematsu, K, Yamaguchi, T, Miyake, Y. Nylon monofilament for intraluminal middle cerebral artery occlusion in rats. Stroke 1995, 26: 1655–1658.
Schmid-Elsaesser, R, Zausinger, S, Hungerhuber, E, Baethmann, A, Reulen, H-J. A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke 1998, 29: 2162–2170.
Kinouchi, H, Epstein, CJ, Mizui, T, et al. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc. Natl Acad. Sci. USA 1991, 88: 11158–11162.
Yang, G, Chan, PH, Chen, J, et al. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 1994, 25: 165–170.
Hata, R, Mies, G, Wiessner, C, et al. A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J. Cereb. Blood Flow Metab. 1998, 18: 367–375.
Roussel, SA, Bruggen, N, King, MD, et al. Monitoring the initial expansion of focal ischemic changes by diffusion-weighted MRI using a remote controlled method of occlusion. Nucl. Magn. Res. Biomed. 1994, 7: 21–8.
Kohno, K, Back, T, Hoehn-Berlage, M, Hossmann, K-A. A modified rat model of middle cerebral artery thread occlusion under electrophysiological control for magnetic resonance investigations. Magn. Reson. Imaging 1995, 13: 65–71.
Röther, J, Crespigny, AJ, D'Arceuil, H, Moseley, ME. MRI detection of cortical spreading depression immediately after focal ischemia in the rat. J. Cereb. Blood Flow Metab. 1996, 16: 214–220.
Zhao, Q, Memezawa, H, Smith, ML, Siesjö, BK. Hyperthermia complicates middle cerebral artery occlusion induced by an intraluminal filament. Brain Res. 1994, 649: 253–259.
Li, F, Omae, T, Fisher, M. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats. Stroke 1999, 30: 2464–2471.
Albers, GW. Antithrombotic agents in cerebral ischemia. Am. J. Cardiol. 1995, 75: 348–388.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group T. Tissue plasminogen activator for acute ischemic stroke. New Engl. J. Med. 1995, 333: 1581–1587.
Futrell, N, Watson, BD, Dietrich, WD, et al. A new model of embolic stroke produced by photochemical injury to the carotid artery in the rat. Ann. Neurol. 1988, 23: 251–257.
Futrell, N. An improved photochemical model of embolic cerebral infarction in rats. Stroke 1991, 22: 225–232.
Hill, NC, Millikan, CH, Wakim, KG, Sayre, GP. Studies in cerebrovascular disease. VII. Experimental production of cerebral infarction by intracarotid injection of homologous blood clot: preliminary report. Mayo Clin. Proc. 1955, 30: 625–633.
Kudo, M, Aoyama, A, Ichimori, S, Fukunaga, N. An animal model of cerebral infarction: homologous blood clot emboli in rats. Stroke 1982, 13: 505–508.
Kaneko, D, Nakamura, N, Ogawa, T. Cerebral infarction in rats using homologous blood emboli: development of a new experimental model. Stroke 1985, 16: 76–84.
Overgaard, K, Sereghy, T, Boysen, G, et al. A rat model of reproducible cerebral infarction using thrombotic blood clot emboli. J. Cereb. Blood Flow Metab. 1992, 12: 484–490.
Busch, E, Kruger, K, Hossmann, K-A. Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res. 1997, 778: 16–24.
Takano, K, Carano, RAD, Tatlisumak, T, et al. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology 1998, 50: 870–875.
Zhang, RL, Chopp, M, Zhang, ZG, Jiang, Q, Ewing, JR. A rat model of focal embolic cerebral ischemia. Brain Res. 1997, 766: 83–92.
Zhang, Z, Zhang, R, Jiang, Q, et al. A new rat model of thrombotic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1997, 17: 123–135.
Zhang, ZG, Chopp, M, Zhang, RL, Goussev, A. A mouse model of embolic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1997, 17: 1081–1088.
Shigeno, T, Teasdale, GM, McCulloch, J, Graham, DI. Recirculation model following MCA occlusion in rats: cerebral blood flow, cerebrovascular permeability, and brain edema. J. Neurosurg. 1985, 63: 272–277.
Shigeno, T, McCulloch, J, Graham, DI, Mendelow, AD, Teasdale, GM. Pure cortical ischemia versus striatal ischemia. Surg. Neurol. 1985, 24: 47–51.
Takizawa, S, Hakim, AM. Animal models of cerebral ischemia. II. Rat models. Cerebrovasc. Dis. 1990, 1(Suppl. 1): 16–21.
Hudgins, WR, Garcia, JH. Transorbital approach to the middle cerebral artery of the squirrel monkey: a technique for experimental cerebral infarction applicable to ultrastructural studies. Stroke 1970, 1: 107–111.
Suzuki, J, Yoshimoto, T, Tanaka, S, Sakamoto, T. Production of various models of cerebral infarction in the dog by means of occlusion of intracranial trunk arteries. Stroke 1980, 11: 337–341.
Slivka, A, Pulsinelli, W. Hemorrhagic complications of thrombolytic therapy in experimental stroke. Stroke 1987, 18: 1148–1156.
Hayakawa, T, Waltz, AG. Immediate effects of cerebral ischemia: evolution and resolution of neurological deficits after experimental occlusion of one middle cerebral artery in conscious cats. Stroke 1975, 6: 321–327.
Robinson, RG, Shoemaker, WJ, Schlumpf, M, Valk, T, Bloom, FE. Effect of experimental infarction in rat brain on catecholamines and behaviour. Nature 1975, 255: 332–334.
Backhauss, C, Karkoutly, C, Welsch, M, Krieglstein, J. A mouse model for focal cerebral ischemia for screening neuroprotective drug effects. J. Pharmacol. Toxicol. Methods 1992, 27: 27–32.
Albanese, V, Tommasino, C, Sparado, A, Tomasello, F. A transbasisphenoidal approach for selective occlusion of the middle cerebral artery in rats. Experientia 1980, 36: 1302–1304.
Tamura, A, Graham, DI, McCulloch, J, Teasdale, GM. Focal cerebral ischemia in the rat. I. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1981, 1: 53–60.
Tamura, A, Graham, DI, McCulloch, J, Teasdale, M. Focal cerebral ischaemia in the rat. II. Regional cerebral blood flow determined by [14C] iodoantypyrine autoradiography following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1981, 1: 61–69.
Bederson, JB, Pitts, LH, Tsuji, M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986, 17: 472–476.
Fox, G, Gallacher, D, Shevde, S, Loftus, J, Swayne, G. Anatomic variation of the middle cerebral artery in the Sprague-Dawley rat. Stroke 1993, 24: 2087–2093.
Chen, ST, Hsu, CY, Hogan, EL, Maricq, H, Balentine, JD. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 1986, 17: 738–743.
Tyson, GW, Teasdale, GM, Graham, DI, McCulloch, J. Focal cerebral ischemia in the rat: topography of hemodynamic and histopathological changes. Ann. Neurol. 1984, 15: 559–567.
Siegel, BA, Meidinger, R, Elliott, AJ, et al. Experimental cerebral microembolism: Multiple tracer assessment of brain edema. Arch. Neurol. 1972, 26: 73–77.
Garcia, JH. Experimental ischemic stroke: a review. Stroke 1984, 15: 5–14.
Takeda, T, Shima, T, Okada, Y, Yamane, K, Uozumi, T. Pathophysiological studies of cerebral ischemia produced by silicone cylinder embolization in rats. J. Cereb. Blood Flow Metab. 1987, 7(Suppl.): S66.
Fukuchi, K, Kusuoka, H, Watanabe, Y, Nishimura, T. Correlation of sequential MR images of microsphere-induced cerebral ischemia with histologic changes in rats. Invest. Radiol. 1999, 34: 698–703.
Gerriets, T, Li, F, Silva, MD, et al. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J. Neurosci. Methods 2003, 122: 201–211.
Watson, BD, Dietrich, WD, Busto, R, Wachtel, MS, Ginsberg, MD. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann. Neurol. 1985, 17: 497–504.
Yoshida, Y, Dereski, MO, Garcia, JH, Hetzel, FW, Chopp, M. Neuronal injury after photoactivation of photofrin II. Am. J. Pathol. 1992, 141: 989–997.
Dietrich, WD, Watson, BD, Busto, R, Ginsberg, MD, Bethea, JR. Photochemically induced cerebral infarction. I. Early microvascular alterations. Acta Neuropathol. (Berlin) 1987, 72: 315–325.
Dietrich, W, Watson, B, Busto, R, et al. Photochemically induced cerebral infarction. II. Edema and blood–brain barrier disruption. Acta Neuropathol. (Berlin) 1987, 72: 326–334.
Ryck, M. Animal models of cerebral stroke: pharmacological protection of function. Eur. J. Neurol. 1990, 3(Suppl.): 21–27.
Robinson, MJ, Macrae, IM, Todd, M, Read, JL, McCulloch, J. Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci. Lett. 1990, 118: 269–272.
Sharkey, J, Ritchie, IM, Kelly, PAT. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 1993, 13: 865–871.
Sharkey, J, Butcher, SP, Kelly, JS. Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and neuroprotective effects of MK801. J. Autonom. Nerv. Syst. 1994, 49: S177–S185.
Wang, LC, Futrell, N, Wang, DZ, et al. A reproducible model of middle cerebral infarcts, compatible with long-term survival, in aged rats. Stroke 1995, 26: 2087–2090.
Sutherland, GR, Dix, GA, Auer, RN. Effect of age in rodent models of focal and forebrain ischemia. Stroke 1996, 27: 1663–1668.
Millikan, CH. Animal stroke models. Stroke 1992, 23: 795–797.
Davis, M, Mendelow, AD, Perry, RH, Chambers, IR, James, OFW. Experimental stroke and neuroprotection in the aging rat brain. Stroke 1995, 26: 1072–1078.
Duverger, D, MacKenzie, ET. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J. Cereb. Blood Flow Metab. 1988, 8: 449–461.
Wiebers, , Adams, HPJ, Whisnant, JP. Animal models of stroke: are they relevant to human disease? Stroke 1990, 21: 1–3.
Alkayed, NJ, Harukuni, I, Kimes, AS, et al. Gender-linked brain injury in experimental stroke. Stroke 1998, 29: 159–165.
Warach, S, Kaste, M, Fisher, M. The effect of GV150526 on ischemic lesion volume: the GAIN Americas and GAIN International MRI Substudy. Neurology 2000, 54(Suppl. 3): A87.
Warach, S, Pettigrew, LC, Dashe, JF, et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Ann. Neurol. 2000, 48: 713–722.
Furlan, A, Higashida, R, Wechsler, L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT (Prolyse in Acute Cerebral Thromboembolism) II study – a randomized controlled trial. J. Am. Med. Ass. 1999, 282: 2003–2011.
Takamatsu, H, Kondo, K, Ikeda, Y, Umemura, K. Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion. Eur. J. Pharmacol. 1998, 362: 137–142.
Sauter, A, Rudin, M. Strain-dependent drug effects in rat middle cerebral artery occlusion model of stroke. J. Pharmacol. Exp. Ther. 1995, 274: 1008–1013.
Jonas, S, Ayigari, V, Viera, D, Waterman, P. Neuroprotection against cerebral ischemia: A review of animal studies and correlation with human trial results. Ann. NY Acad. Sci. 1999, 890: 2–3.
STAIR (Stroke Therapy Academic Industry Roundtable) II Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 2001, 32: 1598–1606.
Fisher, M (for Stroke Therapy Academic Industry Roundtable) Recommendations for advancing development of acute stroke therapies. Stroke 2003, 34: 1539–1546.